These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29931471)

  • 1. Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations.
    Chen C; Wicha SG; Nordgren R; Simonsson USH
    AAPS J; 2018 Jun; 20(4):77. PubMed ID: 29931471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.
    Clewe O; Wicha SG; de Vogel CP; de Steenwinkel JEM; Simonsson USH
    J Antimicrob Chemother; 2018 Feb; 73(2):437-447. PubMed ID: 29136155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models.
    Chen C; Wicha SG; de Knegt GJ; Ortega F; Alameda L; Sousa V; de Steenwinkel JEM; Simonsson USH
    CPT Pharmacometrics Syst Pharmacol; 2017 Nov; 6(11):787-797. PubMed ID: 28657202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development.
    Susanto BO; Wicha SG; Hu Y; Coates ARM; Simonsson USH
    Clin Pharmacol Ther; 2020 Aug; 108(2):274-286. PubMed ID: 32080839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions.
    Wicha SG; Chen C; Clewe O; Simonsson USH
    Nat Commun; 2017 Dec; 8(1):2129. PubMed ID: 29242552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
    Svensson RJ; Gillespie SH; Simonsson USH
    J Antimicrob Chemother; 2017 Aug; 72(8):2311-2319. PubMed ID: 28520930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient measurement and factorization of high-order drug interactions in
    Cokol M; Kuru N; Bicak E; Larkins-Ford J; Aldridge BB
    Sci Adv; 2017 Oct; 3(10):e1701881. PubMed ID: 29026882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.
    Meletiadis J; Verweij PE; TeDorsthorst DT; Meis JF; Mouton JW
    Med Mycol; 2005 Mar; 43(2):133-52. PubMed ID: 15832557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic model.
    Zhuang L; Sy SK; Xia H; Singh RP; Mulder MB; Liu C; Derendorf H
    Int J Antimicrob Agents; 2015 Feb; 45(2):151-60. PubMed ID: 25465523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model.
    Chen C; Ortega F; Rullas J; Alameda L; Angulo-Barturen I; Ferrer S; Simonsson US
    J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):133-141. PubMed ID: 28205025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.
    Deshpande D; Srivastava S; Nuermberger E; Pasipanodya JG; Swaminathan S; Gumbo T
    Clin Infect Dis; 2016 Nov; 63(suppl 3):S88-S94. PubMed ID: 27742639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized Rhombic Experimental Dynamic Checkerboard Designs to Elucidate Pharmacodynamic Drug Interactions of Antibiotics.
    Kroemer N; Aubry R; Couet W; Grégoire N; Wicha SG
    Pharm Res; 2022 Dec; 39(12):3267-3277. PubMed ID: 36163408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin-Treated Pulmonary Tuberculosis.
    Svensson RJ; Simonsson U
    CPT Pharmacometrics Syst Pharmacol; 2016 May; 5(5):264-73. PubMed ID: 27299939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.
    Goldoni M; Johansson C
    Toxicol In Vitro; 2007 Aug; 21(5):759-69. PubMed ID: 17420112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs.
    Davies GR; Nuermberger EL
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S65-74. PubMed ID: 18762154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical formulation of additivity for antimicrobial agents.
    Boucher AN; Tam VH
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):319-25. PubMed ID: 16626903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions.
    Meletiadis J; te Dorsthorst DT; Verweij PE
    Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and modelling of antibacterial combination regimens.
    Rao GG; Li J; Garonzik SM; Nation RL; Forrest A
    Clin Microbiol Infect; 2018 Jul; 24(7):689-696. PubMed ID: 29269090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro.
    Clewe O; Aulin L; Hu Y; Coates AR; Simonsson US
    J Antimicrob Chemother; 2016 Apr; 71(4):964-74. PubMed ID: 26702921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel dose-response curves in combination experiments.
    Sühnel J
    Bull Math Biol; 1998 Mar; 60(2):197-213. PubMed ID: 9559575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.